Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

Recruiting now

Conditions studied: Esophagojejunal Anastomotic Leak

In brief

The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following: Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.

Key facts

Study ID

NCT07295236

Run by

Ukrainian Society of Clinical Oncology

People needed

100

Starts

2025-12-01

Expected to finish

2035-12-01

Last updated by the study team

2025-12-29

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients who developed esophago-jejunal anastomotic leak less than 50% of circumference of anastomosis
• patients who developed esophago-jejunal anastomotic leak and remained stable at the moment of diagnosis with no indications for diversion surgery

You may not qualify if…

• unstable patients who developed esophago-jejunal anastomotic leak
• patients who developed esophago-jejunal anastomotic leak more than 50% or anastomotic circumference
• patients who rejected endoscopic vacuum therapy

Where it is running

• National Cancer Institute — Kyiv, Ukraine (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.